Supervised exercise program during chemotherapy for breast, lung and colon cancer
Tests a supervised exercise program before and during chemotherapy in adults with cancer.
Plain-language title generated from the registry record
Registry title: Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer
Key facts
- Where
- Vic, SpainSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 35 and 65 years old?
Source: NCT07502963, who can take part
Where in Spain
- Consorci Hospitalari de VicVic, SpainNo longer taking part
- Facultat de Ciències de la Salut i del Benestar de la Universitat de Vic (UVIC-UCC) Universitat de Vic- Universitat Central de CatalunyaVic, SpainNo longer taking part
- Hospital Universitari de la Santa CreuVic, SpainNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Vic - Central University of Catalonia
- Trial code
- NCT07502963
- Record updated
- 31 March 2026
- Original description
This clinical study evaluates whether a supervised, multimodal therapeutic exercise program started before chemotherapy and continued during treatment can improve treatment outcomes in patients aged 35 to 65 years with breast, lung, or colon cancer.Read full original descriptionShow less
Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer: Randomized Clinical Trial.
This clinical study evaluates whether a supervised, multimodal therapeutic exercise program started before chemotherapy and continued during treatment can improve treatment outcomes in patients aged 35 to 65 years with breast, lung, or colon cancer.
The study hypothesis is that participation in this exercise program improves tolerance to chemotherapy, allowing patients to receive more than 85% of the planned relative dose intensity. In addition, the program is expected to enhance treatment effectiveness by increasing the rate of complete radiological response.
The main objective of the study is to assess the effectiveness of a supervised, multimodal therapeutic exercise program performed before and during chemotherapy in improving both treatment tolerance and treatment efficacy in patients with breast, lung, and colon cancer.
Inclusion: Women and men aged 35 to 65 years; Diagnosed with stage II, III, or IV breast, lung, or colon cancer; Scheduled to start neoadjuvant chemotherapy; Able and willing to provide written informed consent.
Exclusion: Musculoskeletal or neurological disorders that prevent proper execution of the exercises; Uncontrolled infections or symptoms; Comorbidities such as chronic obstructive pulmonary disease (COPD), respiratory failure, or recent cardiovascular events within the past 6 months; Body mass index (BMI) over 35; Pregnant women; Difficulty understanding the purpose and procedures of the study.